---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-025612"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T06:14:52.798096+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Abbott reduces board size from 13 to 12 effective April 29, 2022

## Summary
- Board amended by-laws to set board size at 12 directors, down from 13.
- Change effective April 29, 2022; no reason cited.
- Other by-law provisions remain unchanged.

## SEC filing metadata
- accession: 0001104659-22-025612
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465922025612/0001104659-22-025612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465922025612/tm226900d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-025612
- JSON: https://secwatch.observer/filing/0001104659-22-025612.json
- Plain text: https://secwatch.observer/filing/0001104659-22-025612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.